Multi-omics to Predict Responses to Biologics in IBD

Inclusion Criteria

• •1. For patients with IBD:
• •* Patients with IBD treated with approved biologics
• •* Age 18 or over
• •* Written informed consent obtained from patient for participation
• •2. For non-IBD healthy volunteers:
• •* Patients without the diagnosis of IBD or other conditions that, in the opinion of the investigator, not suitable to participate in the study
• •* Age 18 or over
• •* Written informed consent obtained from patient for participation